BioNTech SE (BNTX)

BioNTech SE is a German biotechnology company based in Mainz that develops and manufactures active immunotherapies for patient-specific approaches to the treatment of diseases.

Indonesia to get Pfizer/BioNTech COVID-19 vaccine from August - ministry

Indonesia will receive 50 million doses of the COVID-19 vaccine jointly made by Pfizer (PFE.N) and BioNTech (22UAy.DE), with the first batch expected in August, a senior health ministry official said ...

BioNTech shots have stronger antibody response than Sinovac, Hong Kong study shows - SCMP

People who are vaccinated against COVID-19 with BioNTech's vaccine were found to have "substantially higher" levels of antibodies than those who received Sinovac's jab, the South China Morning Post re...

Biogen (BIIB) Initiates Late-Stage Study on Lupus Candidate

Biogen (BIIB) is developing its monoclonal antibody candidate, BIIB059, as a potential treatment for active systemic lupus erythematosus....

BioNTech Starts Dosing In Mid-Stage Melanoma Vaccine Trial

BioNTech SE (NASDAQ: BNTX) has dosed the first patient in its Phase 2 trial evaluating the BNT111 cancer vaccine. The study evaluates the therapeutic cancer vaccine candidate BNT111 in combination wit...

Why BioNTech, Moderna, and Novavax Stocks Sank This Week

Shares of BioNTech (NASDAQ: BNTX) were down 10.2% for the week, as of the market close on Thursday. Moderna (NASDAQ: MRNA) stock fell 7.5%, and Novavax (NASDAQ: NVAX) tumbled 14.2%. The decline for ...

Disclaimer: The data contained in Super Surge website is not necessarily real-time nor accurate and may differ from the actual market data. Prices, volumes, ratios, charts and indicators are indicative and not appropriate for trading purposes. Super Surge doesn't bear any responsibility for any trading losses you might incur as a result of using this data.